Summary
Previous studies have shown that the enzyme γ-glutamyl transpeptidase (GGT) is essential for the nephrotoxicity of cisplatin. This study was designed to determine whether GGT activity is necessary for the therapeutic effect of the drug. The relationship between GGT expression and clinical response to platinum-based chemotherapy was examined in 41 human germ cell tumours. Sections of formalin-fixed, paraffin-embedded tumours were immunohistochemically stained with an antibody directed against human GGT. There was no expression of GGT in any of the 17 seminomas or four dysgerminomas; whereas, 12/12 ovarian yolk sac tumours and 4/4 embryonal carcinomas of the testis were GGT-positive. In stage I tumours fewer tumour cells expressed GGT than in later stage tumours. In four germ cell tumours of mixed histology, the seminomatous and dysgerminoma areas were GGT-negative while the areas of the tumour with yolk sac or embryonal histology contained GGT-positive tumour cells. The patients with seminomas or dysgerminomas who were treated with cisplatin-based chemotherapy, all had a complete response despite the absence of GGT expression in these tumours. Fifteen of the 16 patients with yolk sac or embryonal carcinomas received cisplatin-based chemotherapy following surgery. Twelve had a complete response, while three failed to respond to platinum-based therapy. There was no correlation between the level of GGT-expression and response to therapy in this group. Three of the four patients with tumours of mixed histology were treated with cisplatin-based therapy, and had a complete response. Therefore, expression of GGT is not necessary for the therapeutic effect of cisplatin in germ cell tumours. The results from this study suggest that systemic inhibition of GGT would inhibit the nephrotoxic side-effect of cisplatin without interfering with its activity towards germ cell tumours.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
American Joint Committee on Cancer (1997). AJCC Cancer Staging Manual, 5th Ed. Lippincott-Raven: Philadelphia
Bailey, HH, Gipp, JJ & Mulcahy, RT (1994). Increased expression of gamma-glutamyl transpeptidase in transfected tumor cells and its relationship to drug sensitivity. Cancer Lett 87: 163–170.
Chu, G (1994). Cellular responses to cisplatin. J Biol Chem 269: 787–790.
Dekant, W, Vamvakas, S & Anders, MW (1995). Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: cysteine conjugate beta-lyase pathway. In: Advances in Pharmacology, Vol. 27. Anders MW and Dekant W (eds), pp. 115–162. Academic Press: New York
Einhorn, LH (1990). Treatment of testicular cancer: a new and improved model. J Clin Oncol 8: 1777–1781.
FIGO (1988). Annual Report of the Results of Treatment in Gynecological Cancer, Vol. 20. International Federation of Gynecology and Obstetrics: Stockholm
FIGO (1989). Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet 28: 189–193.
Glantz, SA (1992). Primer of Bio-Statics, 3rd edn. McGraw-Hill: New York
Godwin, AK, Meister, A, O’Dwyer, PJ, Huang, CS, Hamilton, TC & Anderson, ME (1992). High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89: 3070–3074.
Hanigan, MH & Ricketts, WA (1993). Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase. Biochemistry 32: 6302–6306.
Hanigan, MH, Frierson, HF Jr, Brown, JE, Lovell, MA & Taylor, PT (1994a). Human ovarian tumors express gamma-glutamyl transpeptidase. Cancer Res 54: 286–290.
Hanigan, MH, Gallagher, BC, Taylor, PT Jr & Large, MK (1994b). Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity. Cancer Res 54: 5925–5929.
Hanigan, MH (1995). Expression of gamma-glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst(e)ine. Carcinogenesis 16: 181–185.
Hanigan, MH & Frierson, HF Jr (1996). Immunohistochemical detection of γ-glutamyl transpeptidase in normal human tissue. J Histochem Cytochem 44: 1101–1108.
Hanigan, MH, Frierson, HF Jr & Taylor, PT Jr (1998). Expression of gamma-glutamyl transpeptidase in stage III and IV ovarian surface epithelial carcinomas does not alter response to primary cisplatin-based chemotherapy. Am J Obstet Gynecol 179: 363–367.
Hochwald, SN, Harrison, LE, Rose, DM, Anderson, M & Burt, ME (1996). Gamma-glutamyl transpeptidase mediation of tumor glutathione utilization in vivo. J Natl Cancer Inst 88: 193–197.
Miller, AB, Hoogstraten, B, Staquet, M & Winkler, A (1981). Reporting results of cancer treatment. Cancer 47: 207–214.
Segelov, E, Campbell, J, Ng, M, Tattersall, M, Rome, R, Free, K, Hacker, N & Friedlander, ML (1994). Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience. J Clin Oncol 12: 378–384.
Sepulveda, AR, Habib, GM, Damjanov, A, Matacic, S, Damjanov, I, Lebovitz, RM & Lieberman, MW (1995). Expression of gamma-glutamyl transpeptidase in midgestational mouse yolk sac and mouse visceral yolk sac carcinoma cells. Exp Cell Res 219: 494–498.
Tew, KD, Monks, A, Barone, L, Rosser, D, Akerman, G, Montali, JA, Wheatley, JB & Schmidt, DE Jr (1996). Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Mol Pharmacol 50: 149–159.
Van’T Sant, P, Sleijfer, DT, Schraffordt Koops, H, Suurmeijer, AJH, Willemse, PHB, De Bruijn, HWA, Marrink, J & Ockhiuzen, T (1984). The pattern of γ-glutamyl transpeptidase, alkaline phosphatase, serum glutamyl oxalate transaminase and serum glutamyl pyruvate transaminase inpatients with disseminated non-seminomatous testicular tumors. Eur J Cancer Clin Oncol 20: 209–215.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Hanigan, M., Frierson, H., Abeler, V. et al. Human germ cell tumours: expression of γ-glutamyl transpeptidase and sensitivity to cisplatin. Br J Cancer 81, 75–79 (1999). https://doi.org/10.1038/sj.bjc.6690653
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690653
Keywords
This article is cited by
-
Inhibition of ?-glutamyl transpeptidase activity decreases intracellular cysteine levels in cervical carcinoma
Cancer Chemotherapy and Pharmacology (2004)